Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christophe Leclercq Added: 3 months ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire… View more
Author(s): S. Chris Malaisrie Added: 3 months ago
CRT 25 - Dr S. Chris Malaisrie (Northwestern University, Evanston, US) joins us to discuss the five-year outcomes from the PARTNER 3 aortic valve-in-valve registry (NCT02675114). The prospective, randomized, multi-center study aimed to assess TAVR with the Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences) compared to aortic valve replacement with a commercially available surgical… View more
Author(s): Baravan Al-Kassou Added: 3 months ago
CRT 25 - Insights on the progression risk in patients with mild to moderate aortic stenosis (AS) show that there was no significant difference in progression rates between mild and moderate AS. However, moderate AS patients had significantly higher mortality rates than mild AS patients at one- and two-year follow ups. The study also suggests that elevated phosphate levels and elevated… View more
Author(s): Patrick W Serruys Added: 1 year ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary… View more
Author(s): David Power Added: 1 year ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the… View more
Author(s): Alexander Fanaroff Added: 1 year ago
CRT 24 - Dr Alexander Fanaroff (Penn Medicine, US) joins us in this short interview to discuss the findings of a national cohort of patients with chronic limb-threatening ischemia, CLIPPER.The CLIPPER cohort includes the baseline data and outcomes of 1.13 million patients with chronic limb-threatening ischemia.Findings from the study showed that for individuals with a diagnosis to limb… View more
Research Area(s) / Expertise:

Electrophysiology & Arrhythmia

Atrial Arrhythmias

Atrial Fibrillation

Pacing, Defibrillators & Cardiac Resynchronisation Therapy

Ventricular Arrhythmias

Job title: University Hospital Coventry, UK
Prof Osman is Consultant Cardiologist / Electrophysiologist, University Hospital Coventry, UK, Honorary Professor of Cardiology (Warwick Medical School)Lead for Cardiac Rhythm Management Several research interests in the field of arrhythmia, including CRT response, AF and Ablation.Special interest: Cardiac Electrophysiology: Atrial Fibrillation, SVT, Atrial Flutter, Ventricular Arrhythmias… View more
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical… View more
Start date: Mar 08, 2025 End date: Mar 11, 2025
Cardiovascular Research Technologies (CRT) 2025 will take place from Saturday March 8th to Tuesday March 11th at the Washington Hilton Hotel in Washington, DC.Cardiovascular Research Technologies (CRT) is a premier educational forum dedicated to the latest advancements in cardiovascular technology and procedures, tailored for physicians and healthcare professionals. CRT offers top-notch education… View more
Research Area(s) / Expertise:
Prof. Christian Veltmann is Head of Heart Rhythm Management in the Department of Cardiology and Angiology at the Hannover Medical School in Hannover, Germany. He has extensive experience in the implantation of pacemakers, ICDs, Cardiac Resynchronization Therapies (CRTs) and leadless pacemakers. Prof. Veltmann participates in the Micra™ Post-Approval Registry and serves as a trainer and proctor in… View more